CLEVELAND and RICHMOND, Calif., Feb. 7, 2018 /PRNewswire/ — Case Western Reserve University and Sangamo Therapeutics, Inc. (Nasdaq: SGMO) today announced the award of an $11 million grant from the National Institutes of Health for a planned study of gene-edited T cells designed to eradica…
